Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy (Q37301237)

19 August 2017

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy (English)

1 reference

Violaine Planté-Bordeneuve

19 August 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

78538

author

5

object named as

Violaine Planté-Bordeneuve

0 references

Richard Labaudinière

11

object named as

Richard Labaudinière

0 references

Jeffery W. Kelly

10

object named as

Jeffery W Kelly

1 reference

19 August 2017

Teresa Coelho

1

1 reference

19 August 2017

Luis F Maia

2

1 reference

19 August 2017

Ana Martins da Silva

3

1 reference

19 August 2017

Márcia W Cruz

4

1 reference

19 August 2017

Ole B Suhr

6

1 reference

19 August 2017

Isabel Conceiçao

7

1 reference

19 August 2017

Hartmut H-J Schmidt

8

1 reference

19 August 2017

Pedro Trigo

9

1 reference

19 August 2017

Jason Chan

12

1 reference

19 August 2017

Jeff Packman

13

1 reference

19 August 2017

Donna R Grogan

14

1 reference

19 August 2017

22 August 2013

1 reference

19 August 2017

1 reference

19 August 2017

260

1 reference

19 August 2017

2802-2814

1 reference

19 August 2017

11

1 reference

Creative Commons Attribution 2.0 Generic

19 August 2017

start time

22 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00415-013-7051-7

0 references

cites work

A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Transthyretin-related familial amyloidotic polyneuropathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Prevention of transthyretin amyloid disease by changing protein misfolding energetics.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

The delayed-start study design.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Familial amyloid polyneuropathy: a clinico-pathologic study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825212

Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival

2 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7051-7

Liver Transplantation Does Not Prevent the Development of Life-Threatening Arrhythmia in Familial Amyloidotic Polyneuropathy, Portuguese-Type (ATTR Val30Met) Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7051-7

Tabulation of human transthyretin (TTR) variants, 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7051-7

Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7051-7

Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients

21 January 2018

1 reference

12 December 2020

Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy

1 reference

12 December 2020

Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis

1 reference

12 December 2020

Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients

1 reference

12 December 2020

Long-term side effects of cyclosporine-based immunosuppression in patients after liver transplantation

1 reference

12 December 2020

Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden

1 reference

12 December 2020

Strjcture of human plasma prealbumin at 2-5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding

1 reference

12 December 2020

Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry

1 reference

12 December 2020

10.1007/S00415-013-7051-7

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference